Avadel Pharmaceuticals (AVDL) has provided an announcement.
Avadel Pharmaceuticals plc is set to become a part of the prestigious Russell 3000® Index, marking a significant milestone for the company. This inclusion, effective from the start of trading on July 1, 2024, signals a noteworthy recognition of the firm’s growth and investment potential within the US equity markets.
For a thorough assessment of AVDL stock, go to TipRanks’ Stock Analysis page.
